Campath (alemtuzumab) - Sanofi
Islet Cell Transplant for Type 1 Diabetes (clinicaltrials.gov) - Oct 27, 2026 - P2 | N=10 | Active, not recruiting | Sponsor: City of Hope Medical Center | Trial completion date: Sep 2026 ➔ Aug 2027 | Trial primary completion date: Sep 2026 ➔ Aug 2027 
Trial completion date • Trial primary completion date • Diabetes • Hypoglycemia • Metabolic Disorders • Transplantation • Type 1 Diabetes Mellitus
http://clinicaltrials.gov/ct2/show/NCT01909245
 
Oct 27, 2026
 
Prev Next